NLRP3 and Insulin resistance: Specifically, the robust increase in IL-1β observed at the periphery in 33i-treated mice support the hypothesis that SIRT2 inactivates NLRP3 inflammasome and prevents aging-associated inflammation and insulin resistance (He et al. 2020), thus its pharmacological inhibition would not be a good strategy, especially in aging.